Kaliumklorid Noridem (Potassium Chloride)

Kaliumklorid Noridem is used to correct potassium deficits in conditions that affect electrolyte balance.

• Hypokalemia: restores normal serum potassium levels in patients with low potassium.
• Potassium depletion due to diuretic therapy: replaces potassium lost from chronic diuretic use.
• Prevention of cardiac arrhythmias related to low potassium: helps maintain cardiac electrophysiology and reduces arrhythmia risk.

• Potassium chloride dissociates after intravenous administration, releasing potassium ions that enter the extracellular fluid. The increased extracellular potassium concentration drives the Na⁺/K⁺‑ATPase pump to restore the normal intracellular‑extracellular potassium gradient, thereby normalising membrane potential, supporting nerve impulse transmission and cardiac muscle contractility.

Kaliumklorid Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Infusion site irritation or pain.
• Transient hyperkalemia with mild symptoms.
• Nausea or vomiting.
• Muscle weakness or cramping.
• Paresthesia (tingling sensations).
• Mild hypotension.

Serious or Rare Side Effects

• Severe hyperkalemia leading to cardiac arrest.
• Life‑threatening arrhythmias.
• Anaphylactic or severe allergic reactions.
• Venous thrombosis at the infusion site.
• Cardiac conduction disturbances.
• Acute renal failure secondary to electrolyte imbalance.

Before using Kaliumklorid Noridem, clinicians should consider several safety measures.

• Monitor serum potassium: check levels before, during, and after infusion.
• Adjust infusion rate: use a controlled rate to avoid rapid potassium spikes.
• Review renal function: reduce dose or avoid if renal impairment is present.
• Avoid in existing hyperkalemia: contraindicated when serum potassium is already elevated.
• Use ECG monitoring: especially in patients with cardiac disease.
• Store below 25°C: keep in the original container, protect from light and moisture.

Kaliumklorid Noridem can interact with other medications that affect potassium balance or cardiac function.

Major Interactions (Avoid)

• ACE inhibitors: may cause excessive potassium accumulation.
• Angiotensin II receptor blockers (ARBs): increase risk of hyperkalemia.
• Potassium‑sparing diuretics (e.g., spironolactone): potentiate potassium rise.
• NSAIDs: reduce renal potassium excretion.
• Trimethoprim‑sulfamethoxazole: can elevate serum potassium.

Moderate Interactions (Monitor Closely)

• Digoxin: heightened risk of digoxin toxicity with high potassium.
• Beta‑blockers: may mask symptoms of hyperkalemia.
• Insulin: potassium shifts intracellularly; monitor levels.
• Glucocorticoids: affect potassium handling.
• Lithium: concurrent use may alter lithium levels.